Intravenous magnesium sulphate vs placebo
Intravenous magnesium sulphate may leads to higher adverse effects: warmth at infusion site compared with placebo (low certainty).
- RR 13.26 [3.23, 54.4]1 study · 202 participantsLow
Intravenous magnesium sulphate may leads to higher adverse effects: warmth at infusion site compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Mixed action antidepressant showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
Buspirone showed no clear difference in participants experiencing adverse effects compared with placebo (low certainty).
Δ9‐Tetrahydrocannabinol preparation showed no clear difference in participants experiencing adverse effects compared with placebo (moderate certainty).
N‐acetylcysteine showed no clear difference in participants experiencing adverse effects compared with placebo (moderate certainty).
It is very uncertain whether selective serotonin reuptake inhibitor antidepressant changes participants experiencing adverse effects compared with placebo (very low certainty).
It is very uncertain whether dietary supplements (Catuama herbal compound) changes adverse effects: exacerbation of symptoms compared with placebo (very low certainty).
Paracetamol (single administration, any dose) showed no clear difference in maternal drug adverse effects (sleepiness) compared with placebo (low certainty).
Laxative may leads to higher adverse effects on women: abdominal cramps compared with placebo (low certainty).
It is very uncertain whether routine antibiotic prophylaxis changes adverse effects of antibiotics (skin rash) compared with no treatment or placebo (very low certainty).
Vitamin A supplementation (200,000 to 400,000 IU) showed no clear difference in infant adverse effects: bulging fontanelle compared with placebo or no treatment (low certainty).
Perampanel add‐on may leads to higher treatment withdrawal due to adverse effects compared with placebo (low certainty).
Analgesic‐decongestant leads to higher adverse effects: dizziness, lightheadedness compared with placebo (high certainty).